Prosomnus Inc

OTC:OSAPQ

Prosomnus, Inc. is a medical technology company, which engages in the business of developing, manufacturing, and marketing precision intraoral medical devices. The company is headquartered in Pleasanton, California and currently employs 129 full-time employees. The company went IPO on 2021-06-15. The Company’s intraoral medical devices are engineered to track the treatment plan and anatomy of each patient. Its precision intraoral devices are Food and Drug Administration (FDA)-cleared, patented and covered by commercial medical insurance, Medicare, TRICARE and other Government-sponsored healthcare plans around the world, representing approximately 200 million covered lives. The Company’s products include ProSomnus EVO Sleep and Snore Device, ProSomnus EVO SELECT Sleep and Snore Device, ProSomnus EVO [PH] Sleep and Snore Device, ProSomnus [CA] LP Sleep and Snore Device and ProSomnus [MOG] Morning Occlusal Guide. The Company’s wholly owned subsidiaries include ProSomnus Holdings, Inc. and ProSomnus Sleep Technologies, Inc.